Data tables for the Eliminating cervical cancer in Canada digital report
Access the data tables and footnotes for the following pages:
- Cervical cancer rates in Canada
- Progress on HPV vaccination in Canada
- Current state of cervical screening
- HPV primary screening progress
- HPV positive screen follow-up
Cervical cancer rates in Canada
Age-standardized incidence rate (per 100,000) for cervical cancer, Canada†, 1994 to 2018
| Year | Incidence |
|---|---|
| 1994 | 10.5 |
| 1995 | 10.6 |
| 1996 | 10.6 |
| 1997 | 9.7 |
| 1998 | 9.7 |
| 1999 | 9.7 |
| 2000 | 9.3 |
| 2001 | 9 |
| 2002 | 9 |
| 2003 | 8.9 |
| 2004 | 8.7 |
| 2005 | 8.1 |
| 2006 | 8.1 |
| 2007 | 8.7 |
| 2008 | 8.4 |
| 2009 | 8.8 |
| 2010 | 8.8 |
| 2011 | 8.4 |
| 2012 | 7.9 |
| 2013 | 7.7 |
| 2014 | 7.9 |
| 2015 | 7.7 |
| 2016 | 8.1 |
| 2017 | 8.1 |
| 2018 | 8.3 |
† Based on trends in age-standardized incidence rates per 100,000 for cervical cancer (females only) from 1994 to 2018, Canada.
Data source: Canadian Cancer Statistics Dashboard, Incidence Trends for Cervical Cancer (Females).
Age-standardized incidence rate (per 100,000) for cervical cancer, by jurisdiction†, 2020
| Jurisdiction | Incidence rate |
|---|---|
| British Columbia | 7.9 |
| Alberta | 8.2 |
| Saskatchewan | 8.1 |
| Manitoba | 10.1 |
| Ontario | 7.8 |
| Quebec | 8.0 |
| New Brunswick | 7.0 |
| Nova Scotia | 6.4 |
| Prince Edward Island | 7.1 |
| Newfoundland and Labrador | 7.4 |
†Data for Canada includes all provinces/territories. Quebec 2020 data was carried forward from 2017 data, Nova Scotia 2020 data was carried forward from 2018 data. Cervical cancer cases in Northwest Territories, Yukon and Nunavut were suppressed due to small numbers.
Data source: Canadian Cancer Registry, Statistics Canada.
Age-standardized incidence rate (per 100,000) for cervical cancer, by neighbourhood income quintile and residence location, Canada†, 2016 to 2018 combined
| Stratification | Classification | Age-standardized incidence rate (per 100,000) |
|---|---|---|
| Neighbourhood income quintile | Q1 – lowest | 9.0 |
| Neighbourhood income quintile | Q2 | 8.5 |
| Neighbourhood income quintile | Q3 | 8.7 |
| Neighbourhood income quintile | Q4 | 7.6 |
| Neighbourhood income quintile | Q5 – highest | 7.3 |
| Location | Rural | 9.4 |
| Location | Urban | 8.0 |
†Data for Canada includes all provinces/territories except Quebec.
Data source: Canadian Cancer Registry, Statistics Canada.
Projected age-standardized incidence rate (per 100,000) for cervical cancer by intervention type, 2018 to 2051
| Year | 50% | 70% | 90% |
|---|---|---|---|
| 2018 | 8.4 | 8.6 | 8.6 |
| 2019 | 8.9 | 9 | 9 |
| 2020 | 8.9 | 8.9 | 8.9 |
| 2021 | 8.9 | 8.7 | 8.7 |
| 2022 | 9.3 | 9.7 | 9.7 |
| 2023 | 8.9 | 8.7 | 8.7 |
| 2024 | 8.9 | 8.9 | 8.9 |
| 2025 | 7.7 | 7.5 | 7.5 |
| 2026 | 9.8 | 9.9 | 9.8 |
| 2027 | 9.4 | 9.2 | 9 |
| 2028 | 9.4 | 9.3 | 9 |
| 2029 | 7.4 | 7.2 | 7 |
| 2030 | 7.4 | 7.4 | 7.1 |
| 2031 | 8.2 | 7.9 | 7.4 |
| 2032 | 6.3 | 6.6 | 6.1 |
| 2033 | 6 | 5.7 | 5.3 |
| 2034 | 6.6 | 6.2 | 5.7 |
| 2035 | 5.7 | 5.1 | 4.7 |
| 2036 | 5.6 | 5.3 | 4.8 |
| 2037 | 6.1 | 5.9 | 5.2 |
| 2038 | 5.4 | 5.1 | 4.5 |
| 2039 | 5.7 | 5.3 | 4.8 |
| 2040 | 5.5 | 5 | 4.3 |
| 2041 | 5.1 | 5.1 | 4.5 |
| 2042 | 5.1 | 4.8 | 4.2 |
| 2043 | 5.3 | 5.1 | 4.2 |
| 2044 | 5.3 | 4.6 | 3.9 |
| 2045 | 5.2 | 4.9 | 4.1 |
| 2046 | 5.3 | 5 | 4.4 |
| 2047 | 5.4 | 4.3 | 3.6 |
| 2048 | 4.7 | 4.3 | 3.7 |
| 2049 | 5.2 | 4.6 | 3.6 |
| 2050 | 4.8 | 4.3 | 3.7 |
| 2051 | 5.1 | 4.3 | 3.4 |
Legend:
- 50%: of people in universal school-based vaccination programs vaccinated from 2026 onwards + implementation of HPV primary screening from 2025 onwards*
- 70%: of people in universal school-based vaccination programs vaccinated from 2026 onwards + implementation of HPV primary screening from 2025 onwards*
- 90%: of f people in universal school-based vaccination programs vaccinated from 2026 onwards + 90% of people outside school-based vaccination programs vaccinated up to age 45 by 2025 + implementation of HPV primary screening from 2025 onwards*
*Increasing HPV vaccination rates must be combined with the implementation of HPV primary screening and improved follow-up of screening results to eliminate cervical cancer.
Progress on HPV vaccination in Canada
HPV vaccination rates by province/territory (years vary)
| Province/Territory* | Year | Vaccination rate** | Additional context |
|---|---|---|---|
| British Columbia | 2018-19 | Females: 66.1% Males: 63.5% |
The vaccination rate refers to the percentage of Grade 6 students who received two doses of HPV vaccination, by sex. |
| Alberta | 2021 | Females: 42.6% Males: 40.9% |
The vaccination rate refers to the percentage of people who received a full course of HPV vaccination by age 13, by sex. |
| Saskatchewan | 2017 | Females: 69.1% | The vaccination rate refers to the percentage of female Grade 6 students who received a final dose of HPV vaccination in the reported school year. |
| Manitoba | 2021 | Females by age 13: 58.5% Males by age 13: 57.3 Females by age 17: 72.6% |
The vaccination rate refers to the percentage of children within a reporting year who have received all required doses of the HPV vaccine, by sex and age. |
| Ontario | 2021-22 | 12-year olds: 15.6% 17-year olds: 64.1% |
The vaccination rate refers to the percentage of children up-to-date with the HPV vaccine in the reported school year, by age. |
| Quebec | 2022-23 | Females: 85.0% Males: 82% |
The vaccination rate refers to the percentage of students in secondary 3 who received a final dose of HPV vaccination in the reported school year, by sex. |
| New Brunswick | 2022-23 | Females: 73.0% Males: 66.3% |
The vaccination rate refers to the percentage of Grade 7 students who received a full course of HPV vaccination, by sex. |
| Nova Scotia | 2020-21 | Females: 74.9% Males: 71.9% Overall: 73.1% |
The vaccination rate refers to the percentage of Grade 7 students who received a full course of HPV vaccination in the reported school year, by sex and overall. |
| Prince Edward Island | 2020 | Females: 85.0% Males: 83.5% |
The vaccination rate refers to the percentage of people who received a full course of HPV vaccination, by sex. |
| Newfoundland and Labrador | 2019-20 | Females: 93.4% Males: 91.4% Overall: 92.4% |
The vaccination rate refers to the percentage of Grade 6 students who received a final dose of HPV vaccination in the reported school year, by sex and overall. |
Note: Data not currently available for Yukon, Northwest Territories and Nunavut. Efforts are underway in the territories to build analytic capacity and measurement and reporting capabilities.
*Each province and territory has provided its own content and measures this indicator differently. Because of these differences, data cannot be compared across provinces/territories. Quebec data was gathered from the February 2024 Flash Vigie report.
**All provinces and territories (except Quebec) administer GARDASIL®9 on a two- or three-dose schedule according to the National Advisory Committee on Immunization recommended immunization schedule for HPV vaccines. People under the age of 15 are given two doses.
Percentage of women (aged 18+) with cervical precancer as their most severe Pap test result in a 12-month timeframe, by age group, 2012 to 2018
| Year | Age 18 to 24 | Age 25 to 44 | Age 45 to 69 | Age 70+ |
|---|---|---|---|---|
| 2012 | 0.704 | 0.535 | 0.162 | 0.334 |
| 2013 | 0.774 | 0.568 | 0.188 | 0.388 |
| 2014 | 0.706 | 0.551 | 0.176 | 0.366 |
| 2015 | 0.667 | 0.545 | 0.157 | 0.41 |
| 2016 | 0.589 | 0.585 | 0.186 | 0.431 |
| 2017 | 0.509 | 0.658 | 0.2 | 0.531 |
| 2018 | 0.467 | 0.623 | 0.187 | 0.452 |
Data source: Provincial and territorial cervical cancer screening programs
Percentage of 14-year old children vaccinated for HPV, by neighbourhood income quintile (before tax), Canada, 2021
| Neighbourhood income quintile | Percent (%) |
|---|---|
| Q1 – lowest | 85.0 |
| Q2 | 80.2 |
| Q3 | 82.3 |
| Q4 | 81.0 |
| Q5 – highest | 89.3 |
Data source: Childhood National Immunization Coverage Survey, Statistics Canada
Percentage of 14-year old children vaccinated for HPV, by location, Canada, 2021
| Location | Percent (%) |
|---|---|
| Rural – very remote | 91.7 |
| Rural – remote | 83.7 |
| Rural | 75.0 |
| Urban | 84.3 |
Data source: Childhood National Immunization Coverage Survey, Statistics Canada
Projected age-standardized incidence rate (per 100,000) for cervical cancer by level of HPV vaccination uptake, 2018 to 2051
| Year | 50% | 70% | 90% |
|---|---|---|---|
| 2018 | 8.4 | 8.6 | 8.6 |
| 2019 | 8.9 | 9 | 9 |
| 2020 | 8.9 | 8.9 | 8.9 |
| 2021 | 8.9 | 8.7 | 8.7 |
| 2022 | 9.3 | 9.7 | 9.7 |
| 2023 | 8.9 | 8.7 | 8.7 |
| 2024 | 8.9 | 8.9 | 8.9 |
| 2025 | 7.7 | 7.5 | 7.5 |
| 2026 | 9.8 | 9.9 | 9.9 |
| 2027 | 9.4 | 9.2 | 9.2 |
| 2028 | 9.4 | 9.3 | 9.3 |
| 2029 | 7.4 | 7.2 | 7.2 |
| 2030 | 7.4 | 7.4 | 7.4 |
| 2031 | 8.2 | 7.9 | 7.9 |
| 2032 | 6.3 | 6.6 | 6.6 |
| 2033 | 6 | 5.7 | 5.7 |
| 2034 | 6.6 | 6.2 | 6.2 |
| 2035 | 5.7 | 5.1 | 5.1 |
| 2036 | 5.6 | 5.3 | 5.3 |
| 2037 | 6.1 | 5.9 | 5.9 |
| 2038 | 5.4 | 5.1 | 5.1 |
| 2039 | 5.7 | 5.3 | 5.3 |
| 2040 | 5.5 | 5 | 5 |
| 2041 | 5.1 | 5.1 | 5.1 |
| 2042 | 5.1 | 4.8 | 4.8 |
| 2043 | 5.3 | 5.1 | 5 |
| 2044 | 5.3 | 4.6 | 4.5 |
| 2045 | 5.2 | 4.9 | 4.9 |
| 2046 | 5.3 | 5 | 4.9 |
| 2047 | 5.4 | 4.3 | 4.3 |
| 2048 | 4.7 | 4.3 | 4.3 |
| 2049 | 5.2 | 4.6 | 4.5 |
| 2050 | 4.8 | 4.3 | 4.2 |
| 2051 | 5.1 | 4.3 | 4.3 |
Legend:
- 50%: of people in universal school-based vaccination programs vaccinated from 2024 onwards + implementation of HPV primary screening from 2025 onwards*
- 70%: of people in universal school-based vaccination programs vaccinated from 2024 onwards + implementation of HPV primary screening from 2025 onwards*
- 90%: of people in universal school-based vaccination programs vaccinated from 2024 onwards + implementation of HPV primary screening from 2025 onwards*
*Increasing HPV vaccination rates must be combined with the implementation of HPV primary screening and improved follow-up of screening results to eliminate cervical cancer.
Current state of cervical screening
Cervical screening coverage and program status
| Jurisdiction | Program status* | Screening coverage (%)** |
|---|---|---|
| British Columbia | Organized population based screening | 74.9 |
| Alberta | Organized population based screening | 81.2 |
| Saskatchewan | Organized population based screening | 80.2 |
| Manitoba | Organized population based screening | 80.8 |
| Ontario | Organized population based screening | 78.5 |
| Quebec | Program announced or planned | 70.1 |
| New Brunswick | Organized population based screening | 80.2 |
| Nova Scotia | Organized population based screening | 80.6 |
| Prince Edward Island | Organized population based screening | 71.3 |
| Newfoundland and Labrador | Organized population based screening | 83.5 |
| Yukon | Opportunistic screening | 0 |
| Northwest Territories | Program announced or planned | 0 |
| Nunavut | Opportunistic screening | 0 |
*Each province and territory provided its program status as of October 2023.
**Age standardized to 2011 Canadian population. Denominator excludes women who have had a hysterectomy. Data source: Statistics Canada. Canadian Community Health Survey
Data source: Statistics Canada. Canadian Community Health Survey
Percentages of women (aged 21-69) reporting at least one Pap test in the past three years, 2017
| Stratification | Classification | Coverage rate (%) |
|---|---|---|
| Neighbourhood income quintile | Q1 – lowest | 66.2 |
| Neighbourhood income quintile | Q2 | 73.3 |
| Neighbourhood income quintile | Q3 | 79.9 |
| Neighbourhood income quintile | Q4 | 80.9 |
| Neighbourhood income quintile | Q5 – highest | 82.4 |
| Immigration status | <10 years | 63.5 |
| Immigration status | ≥10 years | 75.3 |
| Immigration status | Canadian born | 78.8 |
| Location | Rural – very remote | 75.8 |
| Location | Rural – remove | 72.5 |
| Location | Rural | 75.4 |
| Location | Urban | 77.1 |
Age standardized to 2011 Canadian population. Denominator excludes women who have had a hysterectomy.
Data source: Statistics Canada. Canadian Community Health Survey
HPV primary screening progress
HPV screening in Canada, 2024
| Jurisdiction | Level of implementation | Additional context |
|---|---|---|
| British Columbia | Partial implementation | Plans for HPV self-screening |
| Alberta | Planning for implementation | Plans for HPV self-screening |
| Saskatchewan | Planning for implementation | |
| Manitoba | Planning for implementation | Plans for HPV self-screening |
| Ontario | Planning for implementation | |
| Quebec | Planning for implementation | |
| New Brunswick | Planning for implementation | Plans for HPV self-screening |
| Nova Scotia | Planning for implementation | Plans for HPV self-screening |
| Prince Edward Island | Jurisdiction-wide implementation | Plans for HPV self-screening |
| Newfoundland and Labrador | Planning for implementation | |
| Yukon | Planning for implementation | |
| Northwest Territories | Planning for implementation | Plans for HPV self-screening |
| Nunavut | No current HPV primary screening activities |
Each province and territory provided its implementation status as of January 2024.
HPV Positive Screen Follow-Up
Projected colposcopy demand, 2023 to 2053
Description: Colposcopy demand modelling projections using the OncoSim-Cervix tool. Implementation follows an age-based approach (aged >50 first, followed by aged >40, and lastly aged >= 25).
| Year | Age-based transition over 7y to HPV testing every 5y | Age-based transition over 3y to HPV testing every 5y | Immediate transition to HPV testing every 5y | Pap testing every 3y |
|---|---|---|---|---|
| 2023 | 228,413 | 228,413 | 228,413 | 228,413 |
| 2024 | 228,082 | 228,082 | 283,970 | 218,505 |
| 2025 | 214,871 | 226,910 | 294,098 | 205,529 |
| 2026 | 212,674 | 256,232 | 287,664 | 202,594 |
| 2027 | 204,726 | 248,502 | 185,089 | 201,765 |
| 2028 | 184,421 | 202,890 | 84,475 | 198,033 |
| 2029 | 204,409 | 148,703 | 145,072 | 199,433 |
| 2030 | 205,588 | 127,720 | 207,359 | 198,680 |
| 2031 | 173,033 | 162,935 | 213,191 | 194,865 |
| 2032 | 170,163 | 180,014 | 146,367 | 193,906 |
| 2033 | 140,032 | 150,163 | 78,961 | 193,379 |
| 2034 | 120,478 | 115,400 | 119,929 | 188,920 |
| 2035 | 123,717 | 106,276 | 156,689 | 187,671 |
| 2036 | 121,582 | 129,411 | 158,331 | 187,240 |
| 2037 | 128,180 | 138,155 | 112,622 | 186,074 |
| 2038 | 113,155 | 117,417 | 67,987 | 186,126 |
| 2039 | 102,986 | 93,391 | 100,270 | 184,868 |
| 2040 | 104,833 | 92,091 | 129,306 | 182,941 |
| 2041 | 100,173 | 109,994 | 129,669 | 183,686 |
| 2042 | 107,571 | 117,845 | 95,914 | 183,447 |
| 2043 | 98,089 | 100,580 | 62,500 | 182,986 |
| 2044 | 90,279 | 81,050 | 89,881 | 183,557 |
| 2045 | 89,967 | 80,051 | 110,600 | 184,639 |
| 2046 | 85,064 | 94,490 | 109,970 | 184,569 |
| 2047 | 92,247 | 101,875 | 83,839 | 184,093 |
| 2048 | 88,254 | 91,485 | 59,986 | 185,243 |
| 2049 | 82,916 | 75,103 | 82,579 | 185,121 |
| 2050 | 82,515 | 72,400 | 98,628 | 187,127 |
| 2051 | 78,350 | 84,321 | 96,972 | 186,651 |
| 2052 | 83,185 | 90,874 | 76,783 | 185,046 |
| 2053 | 78,185 | 82,189 | 57,428 | 184,944 |